Published in J Biol Stand on January 01, 1987
A re-appraisal of the biochemical map of foot-and-mouth disease virus RNA. J Gen Virol (1978) 2.06
Purification and identification of the RNA-dependent RNA polymerase of foot-and-mouth disease virus. J Gen Virol (1979) 1.50
Effects of estradiol and progesterone on susceptibility and early immune responses to Chlamydia trachomatis infection in the female reproductive tract. Infect Immun (2000) 1.42
A T cell epitope in VP1 of foot-and-mouth disease virus is immunodominant for vaccinated cattle. J Immunol (1991) 1.31
Mouse neurovirulence determinants of poliovirus type 1 strain LS-a map to the coding regions of capsid protein VP1 and proteinase 2Apro. J Virol (1994) 1.25
Foot-and-mouth disease: the risk for Great Britain after 1992. Vet Rec (1992) 1.25
Tryptic peptide analysis of the structural proteins of vesicular stomatitis virus. J Gen Virol (1978) 1.24
A model for vesicular exanthema virus, the prototype of the calicivirus group. J Gen Virol (1978) 1.22
Thermal stability of foot-and-mouth disease virus. Arch Virol (1981) 1.22
Isotype responses of infected, virus-vaccinated and peptide-vaccinated cattle to foot-and-mouth disease virus. Vaccine (1990) 1.19
Moleculas aspects of the antigenic variation of swine vesicular disease and Coxsackie B5 viruses. J Gen Virol (1977) 1.10
T cell-dependent induction of antibody against foot-and-mouth disease virus in a mouse model. J Gen Virol (1989) 1.01
Chlamydia trachomatis infection in the female reproductive tract of the rat: influence of progesterone on infectivity and immune response. Infect Immun (1998) 1.00
High-affinity antibody induced by immunization with a synthetic peptide is associated with protection of cattle against foot-and-mouth disease. Immunology (1991) 0.99
International bank for foot-and-mouth disease vaccine: assessment of Montanide ISA 25 and ISA 206, two commercially available oil adjuvants. Vaccine (1996) 0.98
Construction and characterization of a poliovirus/rhinovirus antigenic hybrid. Virology (1991) 0.98
Chlamydia pneumoniae infection significantly exacerbates aortic atherosclerosis in an LDLR-/- mouse model within six months. Mol Cell Biochem (2000) 0.97
Heterotypic recognition of recombinant FMDV proteins by bovine T-cells: the polymerase (P3Dpol) as an immunodominant T-cell immunogen. Virus Res (1998) 0.95
Heterotypic recognition of foot-and-mouth disease virus by cattle lymphocytes. J Gen Virol (1990) 0.95
MHC class II restricted recognition of FMDV peptides by bovine T cells. Immunology (1991) 0.94
Detection of foot-and-mouth disease viral sequences in clinical specimens and ethyleneimine-inactivated preparations by the polymerase chain reaction. Vaccine (1993) 0.93
Biochemical aspects of variation in foot-and-mouth disease virus. J Gen Virol (1980) 0.91
The expression of the proteins of equine herpesvirus 1 which share homology with herpes simplex virus 1 glycoproteins H and L. Virus Res (1996) 0.91
Comparative immunogenicity of 146S, 75S and 12S particles of foot-and-mouth disease virus. Arch Virol (1982) 0.87
Mouse protection test as a predictor of the protective capacity of synthetic foot-and-mouth disease vaccines. Vaccine (1991) 0.85
Synthetic peptide vaccines against foot-and-mouth disease. I. Duration of the immune response and priming in guinea-pigs, rabbits and mice. J Biol Stand (1987) 0.83
An international collaborative study on foot and mouth disease virus assay methods. 2. Quantification of 146S particles. J Biol Stand (1985) 0.82
Further developments in the quantification of small RNA viruses by U.V. photometry of sucrose density gradients. Dev Biol Stand (1981) 0.81
Studies on glycoprotein 13 (gp13) of equid herpesvirus 1 using affinity-purified gp13, glycoprotein-specific monoclonal antibodies and synthetic peptides in a hamster model. J Gen Virol (1991) 0.81
Maturation of functional antibody affinity in animals immunised with synthetic foot-and-mouth disease virus. Res Vet Sci (1992) 0.79
The elution of foot-and-mouth disease virus from vaccines adjuvanted with aluminium hydroxide and with saponin. J Biol Stand (1982) 0.78
Prospects for improved foot and mouth disease vaccines. Vaccine (1985) 0.78
Induction of antibody to foot-and-mouth disease virus in presensitized mouse spleen cell cultures. J Virol (1984) 0.75
Poliovirus vaccination schedules and reversion to virulence. J Infect Dis (1992) 0.75
Observations and implications of proteolysis in preparations of foot-and-mouth disease virus. Dev Biol Stand (1981) 0.75
The evaluation of a physical method for the quantification of inactivated poliovirus particles and its relationship to D-antigenicity and potency testing in rats. J Biol Stand (1984) 0.75
Synthetic peptide vaccines against foot and mouth disease. Vaccine (1986) 0.75
The stability and potency of vaccines prepared from inactivated foot-and-mouth disease virus concentrates. J Biol Stand (1984) 0.75
The detection and inhibition of proteolytic enzyme activity in concentrated preparations of inactivated foot-and-mouth disease virus. J Biol Stand (1983) 0.75
Isolation of capsid proteins of foot-and-mouth disease virus by chromatofocusing. J Virol Methods (1983) 0.75
The production and use of swine vesicular disease virus from pig kidney monolayer cells grown on the surface of 3-mm-diameter glass spheres. Biotechnol Bioeng (1982) 0.75
[Effects of temperature and inactivators on strains of foot-and-mouth disease virus in Colombia]. Rev Latinoam Microbiol (1984) 0.75
Qualitative assessment of 146 S particles of foot-and-mouth disease virus in preparations destined for vaccines. J Biol Stand (1982) 0.75
A comparative study of the surface projections of different strains of vesicular stomatitis virus. J Gen Virol (1975) 0.75
Interactions between saponin and 146S particles of foot-and-mouth disease virus. J Biol Stand (1982) 0.75